1017 1000 MG Pill - white oval, 20mm
Pill with imprint 1017 1000 MG is White, Oval and has been identified as Levetiracetam 1000 mg. It is supplied by Torrent Pharmaceuticals.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1017 1000 MG
Levetiracetam
- Imprint
- 1017 1000 MG
- Strength
- 1000 mg
- Color
- White
- Size
- 20.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Torrent Pharmaceuticals
- Inactive Ingredients
-
hypromelloses,
magnesium stearate,
polyethylene glycol 400,
povidone k30,
silicon dioxide,
sodium starch glycolate type A potato,
corn starch,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 13668-0017 | Torrent Pharmaceuticals Limited |
| 54868-6076 | Physicians Total Care Inc. (repackager) |
Related images for "1017 1000 MG"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (426)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Injection
- Levetiracetam Oral Solution
- Levetiracetam Tablets
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.